CLAIM #43556 · Merck & Company Inc (MRK) · 2025Q2 earnings call · Jul 29, 2025
“We will and we need to fully fund behind those launches. We need to continue and we will fully fund behind our Phase III pipeline on an R&D basis.”
Robert Davis · CEO
Verdict
PENDING
Direction
up
Magnitude
–
Due
Jul 29, 2026
Metric
unmapped
Intensity
confident
How to check this claim
This claim states no checkable outcome, so Maat records it without grading it.
Verify independently
SEC filings for MRK ↗ · Quote is verbatim from the 2025Q2 earnings call.